FDA Drug Application (016997) for SERENTIL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number016997
Product Number001
FormCONCENTRATE;ORAL
DosageEQ 25MG BASE/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSERENTIL
Active IngredientMESORIDAZINE BESYLATE



Back to FDA Applications sponsored by NOVARTIS